Further, Lonca showed potent cytotoxicity in a panel of six B‐cell NHL human cell lines with different levels of CD19 expression and CD19 copy numbers, as measured by IHC and flow cytometry, respectively. Here, CD19 is linked to B-cell non-Hodgkin lymphoma.